# Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

> **NCT00875615** · PHASE2 · COMPLETED · sponsor: **University of Miami** · enrollment: 11 (actual)

## Conditions studied

- Liver Cancer

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Cisplatin
- **DRUG:** Sorafenib

## Key facts

- **NCT ID:** NCT00875615
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2017-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00875615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00875615, "Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT00875615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*